Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Appl Thromb Hemost ; 30: 10760296241247203, 2024.
Article in English | MEDLINE | ID: mdl-38619922

ABSTRACT

Venous thromboembolism (VTE) is a leading cause of maternal mortality. Obesity and cesarean delivery are established risk factors for pregnancy-related VTE. We identified additional risk factors among patients with obesity who underwent a cesarean delivery to identify those who need VTE prophylaxis. We conducted a secondary analysis of data from the Maternal-Fetal Medicine Units Network (MFMU) Cesarean Registry Database using a case-control design. Cases were identified as women with obesity having a pre-pregnancy body mass index of >30 kg/m2, who underwent cesarean delivery and subsequently developed deep venous thrombosis (DVT) or pulmonary embolism (PE). These women were compared to a control group of women with obesity who underwent cesarean delivery but did not develop DVT or PE. Analysis of risk factors associated with VTE was performed using Chi-Square test and Fisher's exact test. We identified 43 VTE cases and 172 controls in the MFMU database. Increased risk of VTE was noted in women with endometritis (OR of 4.58 [95% CI: 1.86-11.2, P = .0004]), receiving a blood transfusion (OR 17.07 [95% CI: 4.46-65.3, P = .0001]), having a coagulopathy (OR 27.73 [95% CI: 3.24-237.25, P = .0003]), and urinary tract infection (OR 2.39 [95% CI: 1.08-5.28, P = .03]). Important risk factors for VTE in women with obesity who undergo cesarean delivery include endometritis, intra- or post-operative transfusion, coagulopathy, and urinary tract infection. The presence of one or more of these factors may help guide provider decision-making regarding whether to administer thromboprophylaxis.


Subject(s)
Endometritis , Pulmonary Embolism , Urinary Tract Infections , Venous Thromboembolism , Pregnancy , Humans , Female , Venous Thromboembolism/prevention & control , Anticoagulants/therapeutic use , Endometritis/chemically induced , Endometritis/complications , Endometritis/drug therapy , Pulmonary Embolism/etiology , Risk Factors , Obesity/complications , Obesity/drug therapy , Urinary Tract Infections/chemically induced , Urinary Tract Infections/complications , Urinary Tract Infections/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...